 

UUID: CBCEBZBC- -E6F5- 4715- 97F0- ZTBSBEBCBESSAac
TCGA- CC- ABHU- OlA-PR

 

I“Mllllllll|l||l|Illllllllll|IIIIIIHIIIIIIIIIIIIIIIIIlllllil|||||||c||Ed
Ill||I|||||||IlllllllllllllllllllHl|||||||||I||||||||||||I||||| - ‘ 7...
Clinical Case Report
(For Collection of Cancerous Tissue) ) . _>
(i A .120 -o- :5
(«9th math (igm‘tﬂgﬂapm NOS
1 I 8/7013

 

[Informed Consenti ﬁt qg ,1 1/2 5/13

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes I reviewed the ' ,_ -_ ,

l with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained—at“

0111' institution.

7—, - “—7— - - ‘
Name of Physician or Study Coordinator -Ignature uate

 

Klinical Informatiorﬂ

 

 

 

 

 

 

 

 

 

 

 

GENERAL INFORMATION _ ,
new Birth (mm/dyimylL‘, Hei M y, l MaritaL Status Rae. l Temperature
‘ ‘ L ‘ I”\»,:,’r,._)(\f 75"?) Lil-(‘,-..
Gender / | Weight I Blood Erasure Heart Rate

 

-. HISTORY OF PRESENT ILLNESS ' ,
ChiefComplaints: 5450!“)er W Km 34 / vdagw 6km; («fame/U .

Symptoms: UV 9,4" M £0 S 5

Clinical Findings:

 

 

 

 

Performance Scale (Karnofsky Score):
Cl 100 Asymptomatic CI 80-90 Symptomatic but Fully Ambulatory D 60- 70 Symptomatic, In bed less than 50% of day
0- 50 Symptomatic, in bed more than 50% of day, but not bed ridden El 20- 30 Bed Ridden

 

 

 

CURRENT MEDICATIONS
Dose Route

 

PAST MEDICAL HISTORY
Disease Disorder

Date

T

 

 

 

 

 

 

OBI’GYN HISTORY I
Menopausal Status Date of First Menses # of Pregnancies
ﬁnPre-menopausal - Mm ”Inf 0 .2,
I3 Peri~Menopausal Date of Last Menses # of Live Births
U Post-menopausal (9 Z

 

 

 

Birth Control: I: Cendom El Oral Contraceptive

D Other:

PIUD

 

El Hormone Replacement
Therapy:

 

El YES

C] YES

NO

Status
NO

Current Status

D YES

NO

Relative I

SOCIAL HISTORY

Environmental Hazards:

Smoki

Alcohol Consum

TYPE

Use

Y MEDICAL

Duration

Duration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.- _. _ _ LABDATAV-~;, .. . . _
Test Result l Date [2 r] Test Result Date
HIV @Negative D Positive: CEA El Negative 1:! Positive:

Hep B Wegative 1:] Positive: CA [5-3 m Negative El Positive:
Hep C Wﬁaﬁve D Positive: CA 19-9 0 Negative CI Positive:
AFP El Negative MPositive: PSA C] Negative D Positive:
Other: El Negative El Positive: Other: El Negative El Positive:
B/I‘ Cell Markers:

 

 

 

DIAGNOSTIC STUDIES

Ultrasound
X-Ra
CT

MRI
Bi

CLINICAL DIAGNOSIS
Cl
0/
Location of Involved L Nodes Location of Distant Metastasis

Clinical Dateof
T N o M Stage: /

 

 

[Treatment Informatioﬂ

SURGICAL TREATMENT I. -
Procedure Date of Procedure

\

Tumor
Detailed Location

I

of'l' ‘

Nodes
Location of L Nodes
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes

Distant Metastasis
Location

T N M

NEOADJUVENT THERAPY or Molecular
Dose Route Date
/ To
To
To
To
To

 

Pathology Form

 

[Specimen Informationl

 

 

 

 

 

 

 

 

 

 

 

Collected by: _ I Date - l‘ime'
Preserved by: __ V . _ Date. _Timt
. SPECIMEN TYPE (# of samples provided) .
Frozen Parafﬁn Block BloodlSerum/Plasmn Slide
Diseased Normal Diseased Normal Diseased Nomal Diseased Normal
2 4 2 ’4/ L
ITime to LNZ ﬁrm to Formalin Time to LN2 ~ . wr .
V min , min min

 

 

 

 

 

 

PATHOLOGICAL DESCRIPTION
Prima Tumor
Size Extension of Tumor Distance to NA
’3? x cm ' cm

Nodes
# Examined # Metastaslzed

Distant Metastasis

 

 

 

anRevlsedi

Consolidated Pathology Diagnosis

 

 

 

 

 

 

 

 

Director. Research Pathology
mm REPORT OF FINDINGS WGJuABOMTORs AND

 

